Singapore markets close in 6 hours 36 minutes

China Health Technology Group Holding Company Limited (1069.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.065+0.009 (+16.07%)
As of 10:06AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 40.11M
Enterprise value 159.88M
Trailing P/E 0.02
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.68
Price/book (mrq)2.20
Enterprise value/revenue 73.10
Enterprise value/EBITDA -3.54

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 3-94.40%
S&P500 52-week change 326.27%
52-week high 32.250
52-week low 30.042
50-day moving average 30.051
200-day moving average 30.266

Share statistics

Avg vol (3-month) 32.3M
Avg vol (10-day) 32.99M
Shares outstanding 5716.24M
Implied shares outstanding 6716.24M
Float 8509.43M
% held by insiders 148.42%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 314 Jul 2023

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 350.66%
Operating margin (ttm)-27.75%

Management effectiveness

Return on assets (ttm)-6.26%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)54.72M
Revenue per share (ttm)0.15
Quarterly revenue growth (yoy)-17.40%
Gross profit (ttm)N/A
EBITDA -12.76M
Net income avi to common (ttm)191.86M
Diluted EPS (ttm)3.490
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.51M
Total cash per share (mrq)0
Total debt (mrq)112.23M
Total debt/equity (mrq)667.15%
Current ratio (mrq)1.31
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)2.45M
Levered free cash flow (ttm)-125.56M